Cancer Disparities and Black American Representation in Clinical Trials Leading to the Approval of Oral Chemotherapy Drugs in the United States Between 2009 and 2019

Over the past 10 years, oral chemotherapy made up about half (45.6%) of all US Food and Drug Administration (FDA)–approved oncolytic and hematologic medications. Given the disparity in incidence and mortality rate because of certain cancers among Black Americans (BAs) in the United States, a review...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JCO Oncol Pract
Egile Nagusiak: Ajewole, Veronica B., Akindele, Oyinkansola, Abajue, Uzoamaka, Ndulue, Okwuoma, Marshall, Jazzmin J., Mossi, Yhenew T.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2021
Gaiak:
Special Series: Disparities in Cancer Care for Black People in the United States
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120664/
https://ncbi.nlm.nih.gov/pubmed/33974825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/OP.20.01108
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak